| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Radiology, Mayo Clinic, 200 First St., Rochester, MN
55902.
2 Department of Urology, Mayo Clinic, Rochester, MN 55902.
OBJECTIVE. We performed a retrospective review of imaging-guided radiofrequency ablation of solid renal tumors.
MATERIALS AND METHODS. Since May 2000, 35 tumors in 20 patients have been treated with radiofrequency ablation. The size range of treated tumors was 0.9–3.6 cm (mean, 1.7 cm). Reasons for patient referrals were a prior partial or total nephrectomy (nine patients), a comorbidity excluding nephrectomy or partial nephrectomy (10 patients), or a treatment alterative to nephron-sparing surgery (one patient who refused surgery). Tumors were classified as exophytic, intraparenchymal, or central. Sixteen patients had 31 lesions that showed serial growth on CT or MR imaging. Of these 16 patients, four patients with 10 lesions had a history of renal cell carcinoma, and two patients with 11 lesions had a history of von Hippel-Lindau disease. Four patients had incidental solid masses, two of which were biopsied and shown to represent renal cell carcinoma, and the remaining two masses were presumed malignant on the basis of imaging features. Successful ablation was regarded as any lesion showing less than 10 H of contrast enhancement on CT or no qualitative evidence of enhancement after IV gadolinium contrast-enhanced MR imaging.
RESULTS. Of the 35 tumors, 22 were exophytic and 13 were intraparenchymal. Twenty-seven of the 35 were treated percutaneously using either sonography (n = 22) or CT (n = 5). Two patients had eight tumors treated intraoperatively using sonography. Patients were followed up with contrast-enhanced CT (n = 18), MR imaging (n = 5), or both (n = 5) with a follow-up range of 1–23 months (mean, 9 months). No residual or recurrent tumor and no major side effects were seen.
CONCLUSION. Preliminary results with radiofrequency ablation of exophytic and intraparenchymal renal tumors are promising. Radiofrequency ablation is not associated with significant side effects. Further follow-up is necessary to determine the long-term efficacy of radiofrequency ablation.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  R. N. Uppot, S. G. Silverman, R. J. Zagoria, K. Tuncali, D. D. Childs, and D. A. Gervais Imaging-Guided Percutaneous Ablation of Renal Cell Carcinoma: A Primer of How We Do It Am. J. Roentgenol., June 1, 2009; 192(6): 1558 - 1570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hiraki, H. Gobara, T. Iishi, Y. Sano, T. Iguchi, H. Fujiwara, N. Tajiri, J. Sakurai, H. Date, H. Mimura, et al. Percutaneous radiofrequency ablation for clinical stage I non-small cell lung cancer: results in 20 nonsurgical candidates. J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1306 - 1312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Lokken, D. A. Gervais, R. S. Arellano, K. Tuncali, P. R. Morrison, S. Tatli, P. R. Mueller, and S. G. Silverman Inflammatory Nodules Mimic Applicator Track Seeding After Percutaneous Ablation of Renal Tumors Am. J. Roentgenol., October 1, 2007; 189(4): 845 - 848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. D. Atwell, M. A. Farrell, M. R. Callstrom, J. W. Charboneau, B. C. Leibovich, I. Frank, and D. E. Patterson Percutaneous Cryoablation of Large Renal Masses: Technical Feasibility and Short-Term Outcome Am. J. Roentgenol., May 1, 2007; 188(5): 1195 - 1200. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-Y. Chiou, J.-B. Liu, and L. Needleman Current Status of Sonographically Guided Radiofrequency Ablation Techniques J. Ultrasound Med., April 1, 2007; 26(4): 487 - 499. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. D. Atwell, M. A. Farrell, M. R. Callstrom, J. W. Charboneau, B. C. Leibovich, D. E. Patterson, G. K. Chow, and M. L. Blute Percutaneous Cryoablation of 40 Solid Renal Tumors with US Guidance and CT Monitoring: Initial Experience Radiology, April 1, 2007; 243(1): 276 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kawamoto, S. Permpongkosol, D. A. Bluemke, E. K. Fishman, and S. B. Solomon Sequential Changes after Radiofrequency Ablation and Cryoablation of Renal Neoplasms: Role of CT and MR Imaging RadioGraphics, March 1, 2007; 27(2): 343 - 355. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Brace, P. F. Laeseke, L. A. Sampson, T. M. Frey, D. W. van der Weide, and F. T. Lee Jr Microwave Ablation with a Single Small-Gauge Triaxial Antenna: In Vivo Porcine Liver Model Radiology, February 1, 2007; 242(2): 435 - 440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. S. McDougal, N. E. Tolkoff-Rubin, M. D. Michaelson, P. R. Mueller, and K. Braaten Case 28-2006 -- A 59-Year-Old Man with Masses in Both Kidneys N. Engl. J. Med., September 14, 2006; 355(11): 1161 - 1167. [Full Text] [PDF]
|
|
|
|
|
|
A. Boss, S. Clasen, M. Kuczyk, A. Anastasiadis, D. Schmidt, C. D. Claussen, F. Schick, and P. L. Pereira Thermal Damage of the Genitofemoral Nerve Due to Radiofrequency Ablation of Renal Cell Carcinoma: A Potentially Avoidable Complication Am. J. Roentgenol., December 1, 2005; 185(6): 1627 - 1631. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kariya, N. Tanigawa, H. Kojima, A. Komemushi, Y. Shomura, Y. Ueno, T. Shiraishi, and S. Sawada Radiofrequency Ablation Combined with CO2 Injection for Treatment of Retroperitoneal Tumor: Protecting Surrounding Organs Against Thermal Injury Am. J. Roentgenol., October 1, 2005; 185(4): 890 - 893. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Gervais, F. J. McGovern, R. S. Arellano, W. S. McDougal, and P. R. Mueller Radiofrequency Ablation of Renal Cell Carcinoma: Part 1, Indications, Results, and Role in Patient Management over a 6-Year Period and Ablation of 100 Tumors Am. J. Roentgenol., July 1, 2005; 185(1): 64 - 71. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Ahrar, S. Matin, M. J. Wallace, S. Gupta, and M. E. Hicks Percutaneous Transthoracic Radiofrequency Ablation of Renal Tumors Using an Iatrogenic Pneumothorax Am. J. Roentgenol., July 1, 2005; 185(1): 86 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Merkle, S. G. Nour, and J. S. Lewin MR Imaging Follow-up after Percutaneous Radiofrequency Ablation of Renal Cell Carcinoma: Findings in 18 Patients during First 6 Months Radiology, June 1, 2005; 235(3): 1065 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Lee, J. K. Han, S. H. Choi, S. H. Kim, J. Y. Lee, K. S. Shin, C. J. Han, and B. I. Choi Comparison of Renal Ablation with Monopolar Radiofrequency and Hypertonic-Saline-Augmented Bipolar Radiofrequency: In Vitro and In Vivo Experimental Studies Am. J. Roentgenol., March 1, 2005; 184(3): 897 - 905. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Gillett, M. T. Gettman, H. Zincke, and M. L. Blute Tissue Ablation Technologies for Localized Prostate Cancer Mayo Clin. Proc., December 1, 2004; 79(12): 1547 - 1555. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Hines-Peralta and S. N. Goldberg Review of Radiofrequency Ablation for Renal Cell Carcinoma Clin. Cancer Res., September 15, 2004; 10(18): 6328S - 6334S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Farrell, J. W. Charboneau, M. R. Callstrom, C. C. Reading, D. E. Engen, and M. L. Blute Paranephric Water Instillation: A Technique to Prevent Bowel Injury During Percutaneous Renal Radiofrequency Ablation Am. J. Roentgenol., November 1, 2003; 181(5): 1315 - 1317. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
